newsfilter
← Latest News
GlobeNewswire·

Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

WAYNE, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the "Company") (NASDAQ:PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel